Davis Andrew

Insider profile

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Davis Andrew's trades of Ironwood Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-27 2024-12-27 PrS Proposed sale
21,156
140.99
US$1,152,608
21,156 140.99 US$1,152,608
2024-11-20 2024-11-18 PlS Planned sale
25,505 -25.8%
77.28
US$4,868,154
25,505 -25.8% 77.28 US$4,868,154
2024-11-15 2024-11-18 PrS Proposed sale
67,279
475.63
US$2,547,912
67,279 475.63 US$2,547,912
2024-05-22 2024-05-20 S Sale
22,725 -7.3%
6.45
US$146,576
22,725 -7.3% 6.45 US$146,576
2024-05-17 2024-05-20 PrS Proposed sale
25,105
6.64
US$166,697
25,105 6.64 US$166,697
2024-02-14 2024-02-12 PlS Planned sale
9,846 -4.5%
15.24
US$150,053
9,846 -4.5% 15.24 US$150,053
2024-02-09 2024-02-12 PrS Proposed sale
11,519
14.90
US$171,633
11,519 14.90 US$171,633
2023-11-22 2023-11-20 PlS Planned sale
3,287 -1.5%
9.69
US$31,851
3,287 -1.5% 9.69 US$31,851
2023-11-17 2023-11-20 PrS Proposed sale
3,859
9.44
US$36,429
3,859 9.44 US$36,429
2023-05-24 2023-05-22 S Sale
6,305 -2.8%
10.12
US$63,807
6,305 -2.8% 10.12 US$63,807
2023-05-19 2023-05-22 PrS Proposed sale
7,165
10.22
US$73,226
7,165 10.22 US$73,226
2023-03-01 2023-02-28 S Sale
1,822 -1.2%
11.31
US$20,607
1,822 -1.2% 11.31 US$20,607
2023-03-01 2023-02-27 PlS Planned sale
1,751 -1.1%
11.41
US$19,979
1,751 -1.1% 11.41 US$19,979
2022-11-23 2022-11-21 PlS Planned sale
3,335 -2.1%
11.56
US$38,553
3,335 -2.1% 11.56 US$38,553